Surety Medicine 
Contaminated needles in the medical environment are a concern as a potential source of bloodborne pathogen exposure.  CDC image 

February 2015 Surety Medicine Teleconference 

BLOOD BORNE PATHOGEN PROGRAMS:  REQUIREMENTS FOR PRE- AND POST-EXPOSURE PROPHYLAXES

Wednesday, 18 February 2015 will bring this month’s Surety Medicine Teleconference at
1 pm (1300 hrs) Eastern Time.  February’s presentation will outline the steps to take in evaluating, treating and providing follow-up care or referral for an employee with percutaneous exposure to bodily fluids considered to be blood borne pathogens.

To receive access information for attending the presentation by dial-in audio or on your computer via Defense Connect Online, send an email request to:
usarmy.apg.medcom-phc.mbx.surety-medicine@mail.mil

ALERT:  Latest Update (24 October 2014) - New Injectors and Lot Numbers

NERVE AGENT ANTIDOTE SHELF LIFE EXTENSION PROGRAM

The US Food and Drug Administration (FDA) is alerting health care professionals and emergency responders that specific lots of AtroPen (atropine), CANA (diazepam), morphine sulfate, and pralidoxime chloride auto-injectors manufactured by Meridian Medical Technologies can be used for up to one additional year beyond the manufacturer’s labeled expiration date.  Complete FDA information related to the auto-injector shelf life extension program can be found at:  http://www.fda.gov/Drugs/DrugSafety/ucm376367.htm . 

Information on this page also includes the latest updates (May 2014) on two-year shelf life extensions for the DuoDote combined nerve agent antidote auto-injectors, and includes a link to the 02 October 2014 FDA memo with applicable medication lot and extension date information.    

 ____________________________________________________________________

      SURETY MEDICINE TELECONFERENCE SCHEDULE FOR FY15
            All conferences begin at 1300 hrs / 1 p.m. Eastern Time (US)

 

Presentation Title 
(topics and dates subject to change)

Date

Blood Borne Pathogen Programs: Requirements for Pre- and Post-Exposure Prophylaxes

2/18/2015

Neurological Diseases
and the PRP


3/18/2015
 

Psychological Evaluations for the U.S. Army Personnel Reliability Programs 

4/15/2015 

Assessing Essential Job Functions and Surety Duties through the Worksite Visit Process

5/20/2015

DOT vs. PRP: Evaluation of the CDL Employee

6/17/2015 

Cardiac Evaluation Guidelines for Army Civilian Police

7/15/2015

Permanent Limitations
and the PRP

8/19/2015

Emergency Essential Civilian Employees and the PRP

9/16/2015